根据本次合作协议，STSS 将把其 SOL 财库持仓中的一部分（目前持仓超过 200 万枚 SOL）委托给 Stakin by The Tie 进行质押。Stakin 运营覆盖 40 多个权益证明（Proof-of-Stake）网络的非托管验证节点 基础设施。此次委托将公开市场上规模最大的 Solana 财库策略之一，与生态系统中最成熟的机构级验 证节点运营方之一相结合，不仅增强了网络安全性，也进一步提升了机构参与 Solana 的运营可信度。 纽约 – 2026年2月25日 – Sharps Technology, Inc.（"STSS"或"公司"）（NASDAQ: STSS），一家采用 Solana 数字资产财库战略的医疗器械公司，与行业领先的机构级数字资产分析、合规通信与基础设施服 务提供商 The Tie, Inc.今日宣布达成战略合作，旨在加强 Solana 的机构基础设施建设，并扩大机构投资 者对该生态系统的参与。 The Tie 首席执行官 Joshua Frank 表示： "STSS 正在公开市场上打造最具代表性的 Solana 财库策略之 一，我们很高兴通过我们的验证节点基础设施和机构网络来 ...

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (“STSS” or the “Company”) (NASDAQ: STSS), a medical device company with a Solana digital asset treasury strategy, and The Tie, Inc. (“The Tie”), the leading provider of institutional-grade digital asset analytics, compliant communications, and infrastructure services, today announced a strategic collaboration to strengthen Solana’s institutional infrastructure and expand institutional access to the ecosystem. Under the collaboration, STSS w ...

Core Insights - Sharps Technology, Inc. (STSS) has announced a strategic collaboration with BitGo to enhance its Solana digital asset treasury strategy [1][2] - The partnership aims to utilize BitGo's institutional-grade custody, staking, and trading services to optimize STSS's treasury management [2][4] Company Overview - Sharps Technology is a medical device company focused on innovative safety syringe products and has adopted a digital asset treasury strategy centered on accumulating SOL, the native digital asset of the Solana blockchain [8][9] - BitGo is a digital asset infrastructure company that provides custody, wallets, staking, trading, and other services, serving thousands of institutions globally [10] Strategic Collaboration Details - STSS will leverage BitGo's qualified custody and staking validator services to earn rewards on SOL holdings, consolidating its treasury operations within a single platform [2][4] - The collaboration is designed to provide a secure and scalable operational foundation for STSS's digital asset management [2][4] Market Context - The partnership reflects the growing convergence of institutional digital asset infrastructure and public market adoption, particularly in the context of BitGo's recent IPO [4] - By promoting the growth of the Solana network, STSS aligns itself with major infrastructure providers within the Solana ecosystem [3]

Treasury Updates - Sharps Technology, Inc. has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem [6] - The company's validator partners have generated approximately 7% gross annual percentage yield (APY) before fees, outperforming the Solana network average, with nearly all of the company's SOL holdings currently staked [6] - The company maintains sufficient operating capital and has no corporate debt, indicating a strong financial position [6] Recent Operational Highlights - The company continues to deliver strong revenue from its SOL holdings due to its integration with institutional-quality staking infrastructure [1] - Partnerships with leading validator platforms, combined with institutional-grade controls and execution discipline, position the company to capitalize on the financial benefits of the Solana network [1] - In January, the company launched a jointly supported institutional-grade Solana validator in partnership with Coinbase, delegating a portion of its SOL treasury holdings [6]

Core Insights - Sharps Technology, Inc. has entered into a 90-day lock-up agreement with SOL Markets, indicating strong confidence in its execution roadmap and alignment between the parties [1][2][3] - The company has also announced a share buyback program for up to $100 million, reflecting its commitment to enhancing shareholder value [1] Group 1: Lock-Up Agreement - The lock-up agreement restricts SOL Markets from selling, transferring, or disposing of any warrants or underlying shares of STSS common stock for 90 days, effective January 16, 2026 [2] - This commitment reinforces SOL Markets' alignment with STSS's objectives and demonstrates confidence in the anticipated growth of their combined initiatives [2][3] Group 2: Management and Strategic Partnerships - STSS's management is actively engaging with institutional investors through non-deal roadshows to showcase upcoming initiatives [4] - The company is developing a universal framework for digital identity and authentication through strategic partnerships with Coinbase, Crypto.com, and Jupiter, alongside its Solana treasury and product R&D initiatives [3]

Core Insights - Sharps Technology (STSS) has expanded its relationship with Coinbase Institutional by launching a jointly supported institutional-grade validator on the Solana network [1] - STSS will delegate a portion of its SOL treasury holdings, which exceed 2 million SOL, to the newly established Coinbase-operated validator [1] - The collaboration aims to leverage Coinbase's institutional-grade infrastructure and security standards to ensure high uptime and operational reliability [1] Company Summary - Sharps Technology (STSS) is enhancing its operational capabilities through a partnership with Coinbase Institutional [1] - The company is focusing on the Solana network for its validator operations, indicating a strategic move towards blockchain technology [1] - The partnership is expected to improve the reliability and performance of STSS's validator operations [1]

Core Viewpoint - Sharps Technology, Inc. is expanding its partnership with Coinbase Institutional by launching an institutional-grade validator on the Solana network, marking a significant shift in its role from a participant in digital asset treasury strategies to directly contributing to network security and decentralization [1][3]. Group 1: Partnership and Validator Launch - The new validator, operated by Coinbase, represents an important transition for the company, allowing it to delegate part of its SOL treasury assets to this newly established validator [3]. - The company currently holds over 2 million SOL, and this collaboration integrates Coinbase's institutional-grade infrastructure and operational expertise to ensure high operational stability and reliability of the validator [3]. Group 2: Strategic Implications - The launch of the STSS validator is seen as an extension of the company's involvement in the development and security of the Solana network, leveraging Coinbase's operational capabilities [4]. - With the validator's launch, the company becomes one of the first publicly traded U.S. companies to evolve from merely adopting digital asset treasury strategies to actively participating in blockchain infrastructure development [4]. Group 3: Company Overview - Sharps Technology is an innovative medical device and pharmaceutical packaging company focused on providing patented technology and industry-leading smart safety syringe products, emphasizing ultra-low waste in consumables [5]. - The company's digital asset treasury strategy focuses on accumulating SOL and generating on-chain yields within the Solana ecosystem through capital market financing [5].

Core Viewpoint - Sharps Technology, Inc. is expanding its relationship with Coinbase Institutional by launching an institutional-grade validator on the Solana network, marking a significant shift from being a treasury participant to an active contributor to the network's security and decentralization [1][2]. Group 1: Company Strategy - The company will delegate a portion of its SOL treasury holdings, which currently exceed 2 million SOL, to the newly established Coinbase-operated validator [3]. - This initiative builds on the existing relationship with Coinbase Institutional, leveraging its custody, OTC, and operational infrastructure as part of the broader digital asset treasury strategy [4]. Group 2: Industry Impact - The launch of the STSS Validator positions the company as one of the first U.S.-listed firms to transition from a treasury-only approach to an active participant in blockchain development [5]. - The partnership with Coinbase aims to enhance the security, compliance, and operational reliability of institutional-grade infrastructure, reflecting the growing trend of institutions moving on-chain [5]. Group 3: Company Background - Sharps Technology is a medical device and pharmaceutical packaging company that offers patented smart-safety syringe products, focusing on ultra-low waste capabilities and incorporating advanced safety features [9]. - The company has adopted a digital asset treasury strategy centered on accumulating SOL, the native digital asset of the Solana blockchain, to generate on-chain yield [10].

Core Insights - Several small-cap biotech and healthcare companies experienced notable gains in after-hours trading, driven by recent corporate updates and clinical milestones Company Updates - Inspira Technologies Oxy B.H.N. Ltd. (IINN) rose 5.88% to $1.08 following a recent definitive agreement for a registered direct offering of its ordinary shares and a Standby Equity Purchase Agreement with YA II PN, Ltd. [2] - Galectin Therapeutics Inc. (GALT) increased by 1.79% to close at $6.27, despite no new corporate developments reported [3] - MediciNova, Inc. (MNOV) advanced 4.83% to $1.52 after successfully completing patient enrollment in its Phase 2 OXTOX study, evaluating MN-166 for chemotherapy-induced peripheral neuropathy in metastatic colorectal cancer patients [4] - Marker Therapeutics, Inc. (MRKR) gained 5.56% to $1.33 without any new company-specific announcements [5] - Sharps Technology, Inc. (STSS) climbed nearly 4% to $2.09, also without fresh updates [6] - DiaMedica Therapeutics Inc. (DMAC) rose 2.89% to $8.55 after a productive pre-IND meeting with the FDA regarding its planned study of DM199 in preeclampsia [6] - Corbus Pharmaceuticals Holdings, Inc. (CRBP) edged higher by 1.36% to $8.21, following the completion of its Phase 1a study of CRB-913 and initiation of the Phase 1b CANYON-1 trial [7] - ProMIS Neurosciences, Inc. (PMN) added 0.83% to $8.49, recovering slightly after a decline earlier in the day, with the completion of enrollment of 144 patients in its PRECISE-AD Phase 1b clinical trial for Alzheimer's disease [8]

Core Insights - Sharps Technology, Inc. has reported transformative financial results for Q3 2025, highlighting a strong balance sheet bolstered by a Solana-based treasury strategy and a successful $411 million PIPE financing [2][4] Financial Performance - The company raised gross proceeds of $411 million through a PIPE, consisting of $267 million in cash and stablecoins and $144 million in SOL [8] - As of October 31, 2025, Sharps holds over 2.0 million SOL in its treasury, generating approximately $17.7 million in combined staking revenue and digital-asset fair-value gains during Q3 [8] - Cash and stablecoin liquidity stood at approximately $25.2 million as of September 30, 2025 [8] Strategic Initiatives - The company has exited legacy syringe manufacturing, streamlining operations and reducing costs, allowing it to focus on two strategic priorities: medical device sales and distribution, and maximizing the value of its SOL-based digital asset treasury [8] - Management aims to optimize yields across its Solana ecosystem holdings and leverage capital markets access for long-term growth [4][8] Market Position - The adoption of a Solana-based treasury strategy and the resulting financial strength position Sharps Technology to pursue viable business strategies and deliver long-term value for shareholders [2][4]